Lonza - LSI business

Webinar Date Changed! A PORTFOLIO OF OPPORTUNITIES? Lonza’s Specialty Ingredients Business

 

Note: Due to technical issues resulting from an overwhelming number of people working from home worldwide, our digital platform is having difficulties hosting events. To avoid unnecessary stress to attendees and with hopes that the platform will resolve their technical problems, we are postponing the live webinar to  March 25, 2020.

Webinar Introduction: There have been a number of developments over the years in the biocide industry from regulatory clampdowns through to consolidations and divestments. This brief seminar aims to provide a high-level overview of Lonza’s specialty ingredients business in the context of the biocides and personal care markets.

Continue reading

utraceutical Excipients for OSDFs Market

Consumer Trends Bring New Challenges to Dynamic Excipients for Nutraceutical OSDFs Market

The nutraceutical and, subsequently, excipients market for oral solid dosage forms (OSDFs) is both driven and challenged by consumer awareness. On one hand, rising healthcare costs and the growing consumer focus toward a healthy lifestyle, plus a proactive nutritional approach to avoid chronic diseases, drive the market. On the other hand, consumers are growing more conscious of the health and environmental consequences of products they consume, a trend that is driving the “clean label” movement. These and many other trends and challenges to nutraceutical oral solid dosages are analyzed in the just-published report Excipients for Nutraceutical Oral Solid Dosage Forms: Market Analysis and Opportunities. To learn reports key findings, REGISTER for our upcoming webinar.Continue reading

Biopesticides Market in Italy Set For Rapid Rate Growth in the Next 10 Years

The Italian market of biological pesticides was estimated at approximately USD 160 million in 2019. The industry continues its period of positive growth, with an expected rapid growth through to 2029. Besides seed treatment products, which are estimated to grow the fastest across all crop categories, non-crop for professional usage is forecast to grow at double-digit rates, driven by increasing demand for biopesticides to treat turfs in public and private areas. Continue reading

Upcoming Webinar: Identifying Opportunities within the Nutraceutical Excipients for OSDFs Market

This webinar is based on Kline’s just-published report covering Nutraceutical Excipients for OSDFs Market. It will help you gain a general understanding of the consumption of nutraceuticals globally, but more importantly in the developed markets. The impact of these trends and emerging opportunities they create for ingredients suppliers in this complex and long-term growing market.

Continue reading

Upcoming Webinar: Industrial Surfactants: Global Market Analysis and Opportunities

This webinar is based on Kline’s just-published report covering Industrial Surfactants: Global Market Analysis and Opportunities. It will help you gain a general understanding of industrial applications driven by complex, application-related drivers, whose identification is key for building a successful, targeted business strategy.

Continue reading

biologics excipients and ingredients market

Growth of Biologics and Biosimilars Will Drive Above-Average Demand for a Range of Ingredients

A surging number of biologic APIs and their growing penetration into multiple therapies create an attractive market segment for pharmaceutical ingredient suppliers but not one without challenges, analyzes Kline’s recently published Biologics: Market Opportunities for Chemicals Suppliers. To learn about key findings from the study, REGISTER for a complimentary webinar, taking place on October 17, 2019.

Currently, more than 350 biologics are commercially presented in the biopharmaceuticals market. Some established biologics, such as Humira and Avastin, maintained their growth of the last decade in 2018, with sales growing by 8.2% and 9.5%, respectively. New drugs such as Opdivo, which was first introduced in 2017, witnessed particularly robust growth in the overall biopharmaceutical market.Continue reading

Bright Forecasts Seen for Industrial Surfactants Globally

While HI&I cleaning and personal care applications are relatively well-defined, mapped, and known markets, industrial applications are more complex and fragmented.  A variety of industrial applications in which surfactants may not be a focus for surfactant suppliers is causing a lower degree of rivalry.  The market itself is very fragmented with few larger applications, such as food, crop protection, and lubricants, and many mid-sized and smaller applications. Different end-use applications have various expectations from consumers and unmapped driving forces. Kline’s in-progress report will assist industrial surfactants suppliers by providing them with a clear picture of the market.Continue reading

WOW conference, industrial wipes

Plastic-free movement and sustainability are front-and-center concepts discussed at World of Wipes

In June, hundreds of participants in the wipes market convened for the INDA (Association of the Nonwoven Fabrics Industry) World of Wipes annual meeting in Atlanta, Georgia. There were many presentations from speakers representing industry associations, chemical suppliers, wipes manufacturers, and raw material suppliers. A common theme that was raised pertains to increasing efforts to limit single-use plastic and the plastic-free movement. Many U.S. states and countries, especially in Europe, are phasing out single-use plastics, and by 2021 in Europe, wipes packages will need to contain labeling that shows they “contain plastics” if they do. Since wipes contain plastic components and packaging, the industry needs to keep a watchful eye on this trend.Continue reading

Kline Confirms that Excipients are on the Rise in a New Era for Biologics and Topicals

Biologics:

The global pharmaceutical industry is facing a surge biologics. In recent years, biologic drugs have enjoyed a better approval rating than traditional drugs, as biologic drugs have been found to treat major chronic and complex diseases with higher safety and efficacy. The global production of biologics is expected to grow at a rate of around 10% annually.Continue reading